CIPLA's weekly return of -4.08% was a disappointing performance, accompanied by high volatility of 13.81%. While it outperformed SUNPHARMA and GRASIM, it underperformed DIVISLAB. The stock's Sharpe Ratio of -1.19 and Max Drawdown of -4.08% indicate a high-risk profile this week. Overall, CIPLA's weekly performance was lackluster, with elevated volatility making it a risky bet.

[Volatility: 13.81%]